A circulating miRNA assay as a first-line test for prostate cancer screening

BACKGROUND: Prostate cancer (PCa) screening currently relies on prostate-specific antigen (PSA) testing and digital rectal examination. However, recent large-scale studies have questioned the long-term efficacy of these tests, and biomarkers that accurately identify PCa are needed. METHODS: We analy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Sharova, Evgeniya, Grassi, Angela, Marcer, Anna, Ruggero, Katia, Pinto, Francesco, Bassi, Pierfrancesco, Zanovello, Paola, Zattoni, Filiberto, D'Agostino, Donna M, Iafrate, Massimo, Ciminale, Vincenzo
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Molecular Diagnostics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4984473/
https://ncbi.nlm.nih.gov/pubmed/27228285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.151
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados